CORE LAB REPORTS FIRST QUARTER 2024 RESULTS
/PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's...
Stay updated with breaking news from Core Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's...
Patients having heart bypass surgery can be spared an unpleasant and invasive form of diagnosis following a successful clinical trial led by Irish surgeons, a new study reveals today.
The research found that the approach was 99.1 per cent feasible, with the cardiac CT scanning offering good diagnostic accuracy. The study involved 114 patients who had severe blockages in multiple vessels, limiting blood flow to their heart
The study introduced the concept of using high-resolution cardiovascular imagery and AI-powered blood flow analysis to guide surgical decisions, potentially reducing the need for invasive procedures and enhancing patient care.
A trial co-ordinated by researchers at the University of Galway used high resolution CT scans to identify blockages in coronary arteries.